Evotec SE EVO
NASDAQ EVO
$1.67 +0.05 (+3.09%)
At close: Sep 17, 2026 · 4:00 PM EDT

Evotec SE (EVO) EBT Margin Growth (1y) (2010 - 2025)

Analysis

Evotec SE (EVO) EBT Margin Growth (1y) (2010 - 2025) Analysis & Trends

Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) EBT Margin Growth (1y) (Qtr)
1 Iqvia Holdings 44.72 Bn 42.64 Bn 1.44 Bn -115.00
2 Medpace Holdings 17.37 Bn 16.87 Bn 201.64 Mn 80.00
3 Icon 13.65 Bn 12.72 Bn 479.29 Mn -450.00
4 Charles River Laboratories International 13.13 Bn 12.94 Bn 452.07 Mn -162.00
5 Fortrea Holdings 1.89 Bn 1.72 Bn 139.20 Mn 5,201.00
6 Evotec SE 574.75 Mn 148.87 Mn - -
7 Ginkgo Bioworks Holdings 439.63 Mn 355.09 Mn 18.44 Mn -14,710.00
8 Champions Oncology 69.43 Mn 65.03 Mn 7.70 Mn 51.00
9 MindWalk Holdings 51.76 Mn 46.29 Mn 1.61 Mn -2.77 Mn
10 VivoSim Labs 1.37 Mn 1.37 Mn - -751,066.00
Historic Data

Historic Data

Download Data
DateValue
Dec 31, 2025 3.01 Mn
Sep 30, 2025 -86.00
Jun 30, 2025 -6,643.00
Mar 31, 2025 -210.00
Dec 31, 2024 -4.31 Mn
Jun 30, 2024 5,978.00
Dec 31, 2023 5.27 Mn
Jun 30, 2023 456.00
Dec 31, 2022 -5.69 Mn
Sep 30, 2022 -8.79 Mn
Jun 30, 2022 -4.34 Mn
Mar 31, 2022 -8.26 Mn
Dec 31, 2021 -418.00
Sep 30, 2021 8.21 Mn
Dec 31, 2020 -1,227.00
Jun 30, 2010 9,422.00
Mar 31, 2010 -27,883.00